NanoGroup S.A.'s EBIT is $-19M, below the Healthcare sector average of $1.9T.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
The latest EBIT for NNG.WA is $-19M as of September 2026. That compares with $-6.6M in the prior-year period — down 182.9% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside NanoGroup S.A.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, NNG.WA's EBIT moved from $-6.6M to $-19M — a 182.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NanoGroup S.A.'s operating scale or balance-sheet position.
Against Healthcare companies, NNG.WA currently prints $-19M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at NanoGroup S.A.'s growth, margins, and balance sheet.
A EBIT figure of $-19M for NNG.WA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.
After noting NNG.WA's EBIT ($-19M), review year-over-year change from $-6.6M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.